Core Viewpoint - The company, XinNuoWei, announced on September 16 that it has multiple products entering critical clinical trial stages, emphasizing its commitment to increasing research and development innovation to support long-term growth [2] Group 1 - The company is currently advancing several products into key clinical trial phases [2] - There is a focus on enhancing research and development efforts to expedite the realization of its innovation pipeline [2] - The ongoing innovation initiatives are expected to provide further support for the company's research and long-term development [2]